Anzeige
Mehr »
Login
Mittwoch, 13.11.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
Wir entschlüsseln die 55 $ pro Aktie Clean-Energy-Chance für SIE!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
382 Leser
Artikel bewerten:
(2)

RevitaLash Cosmetics: RevitaLash Cosmetics Champions Breast Cancer Awareness, Research, and Support Worldwide with 2022 Pink Program Announcement

Finanznachrichten News

The Mission-Driven Lash & Brow Leader Expands Its Year-Round Breast Cancer Awareness Efforts Globally

VENTURA, Calif., Oct. 4, 2022 /PRNewswire/ -- RevitaLash Cosmetics is proud to announce the company's annual 2022 Pink Program campaign. In honor of Breast Cancer Awareness month, RevitaLash Cosmetics is launching new activations and supporting existing initiatives, including limited-edition product offerings that help fund breast cancer treatment in Ethiopia and global philanthropic contributions.

RevitaLash Cosmetics Champions Breast Cancer Awareness, Research, and Support Worldwide with 2022 Pink Program Announcement

As category leaders and creators of advanced lash, brow and hair beautification products, RevitaLash Cosmetics' story began with a gift of love from a husband to his adored wife suffering from breast cancer. Today, the company led by founder and CEO, Michael Brinkenhoff, M.D., continues to honor the legacy of Dr. Brinkenhoff's late wife and RevitaLash Cosmetics Co-Founder Gayle Brinkenhoff, who was diagnosed with metastatic breast cancer at age 32. The team is dedicated to extending the circle of love and support to all those affected by this disease through its annual Pink Program efforts.

The 2022 Pink Program focuses its efforts on supporting City of Hope's Ethiopia Breast Cancer Initiative, a program to bring breast cancer screening and treatment to the women of Ethiopia, a region that currently has the highest mortality rates worldwide. The initiative will help fund a nursing education pilot program to train 20-30 nurses, aiming to scale up and expand into a train-the-trainer program in 12 sub-Saharan African countries, eventually reaching approximately 360 nurses. It will also focus on pathology capacity building, aiming to improve breast cancer diagnosis and treatment by training laboratory technicians and providers in tissue processing and analysis, and on strengthening breast cancer treatment in a hospital in Hawassa, Ethiopia which serves 23 million people.

"Through this year's Pink Program expansion, we are honored to have the opportunity to make a bigger impact than ever before. As a global brand in over 70 countries, it's vital to us to help change the state of breast cancer in Ethiopia - with ripple effects felt around the world," says Dariel Sidney, Vice President of Philanthropy and Gayle Brinkenhoff's eldest daughter. "As a cause that is uniquely close to our hearts, the entire RevitaLash Cosmetics family is passionate about directly improving the lives of those dealing with a dif?cult diagnosis, and ultimately eradicating breast cancer. By joining forces with incredible organizations like City of Hope, together we can work towards making our shared vision of a world without breast cancer a reality."

This year from September 1st through October 31st 2022, the award-winning products will be housed in premium, celebratory pink sleeves to honor the cause. For every Pink Sleeve RevitaLash Advanced (3.5mL/2.0mL) and RevitaBrow Advanced (3.0 mL) sold, the company will donate $2 to the annual City of Hope Breast Cancer Symposium and other breast cancer foundations around the globe, up to a maximum donation of $140,000.

City of Hope is one of the largest cancer treatment and research organizations in the United States.

The limited-edition offerings are available in select spas, salons, and specialty retailers and online at revitalash.com, beginning September 1st.

About RevitaLash Cosmetics
RevitaLash Cosmetics is a worldwide leader in developing advanced lash, brow, and hair beautification products. Established in 2006, the collection includes award-winning RevitaLash Advanced Eyelash Conditioner and RevitaBrow Advanced Eyebrow Conditioner, and is available in physician's offices, spas, salons, and specialty retailers across 70 countries. A supporter of non-profit breast cancer initiatives, RevitaLash Cosmetics donates a portion of proceeds to research and education initiatives, giving back to the breast cancer community year-round, not just in October. For information: www.revitalash.com. [RevitaLash Advanced is not available in California]

RevitaLash Cosmetics Logo

Photo - https://mma.prnewswire.com/media/1913564/RL_BCA.jpg
Logo - https://mma.prnewswire.com/media/1216896/RevitaLash_Cosmetics_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/revitalash-cosmetics-champions-breast-cancer-awareness-research-and-support-worldwide-with-2022-pink-program-announcement-301640083.html

© 2022 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.